Evidence map›Paper›PMID 28233833›Full record

ArticleScientific reports2017

Comparison of nanoparticular hydroxyapatite pastes of different particle content and size in a novel scapula defect model.

Veronika Hruschka, Stefan Tangl, Yulia Ryabenkova, Patrick Heimel, Dirk Barnewitz, Günter Möbus, Claudia Keibl, James Ferguson, Paulo Quadros, Cheryl Miller and 4 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Veronika HruschkaLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna, Austria.
Stefan TanglAustrian Cluster for Tissue Regeneration, Vienna, Austria.
Yulia RyabenkovaDepartment of Materials Science and Engineering, The University of Sheffield, Sheffield, United Kingdom.
Patrick HeimelLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna, Austria.
Dirk BarnewitzResearch Center for Medical Technology and Biotechnology, Bad Langensalza, Germany.
Günter MöbusDepartment of Materials Science and Engineering, The University of Sheffield, Sheffield, United Kingdom.
Claudia KeiblLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna, Austria.
James FergusonLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna, Austria.
Paulo QuadrosFluidinova S.A., Moreira da Maia, Portugal.
Cheryl MillerThe School of Clinical Dentistry, University of Sheffield, Sheffield, United Kingdom.
Rebecca GoodchildCeramisys Ltd., Sheffield, United Kingdom.
Wayne AustinCeramisys Ltd., Sheffield, United Kingdom.
Heinz RedlLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna, Austria.
Thomas NauLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna, Austria.
Austrian Cluster for Tissue Regeneration · ATLudwig Boltzmann Institute for Experimental and Clinical Traumatology · ATUniversity of Sheffield · GBResearch Centre of Medical Technology and Biotechnology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanocrystalline hydroxyapatite (HA) has good biocompatibility and the potential to support bone formation. It represents a promising alternative to autologous bone grafting, which is considered the current gold standard for the treatment of low weight bearing bone defects. The purpose of this study was to compare three bone substitute pastes of different HA content and particle size with autologous bone and empty defects, at two time points (6 and 12 months) in an ovine scapula drillhole model using micro-CT, histology and histomorphometry evaluation. The nHA-LC (38% HA content) paste supported bone formation with a high defect bridging-rate. Compared to nHA-LC, Ostim

Indexed as

AnimalsBone CementsBone RegenerationBone SubstitutesBone TransplantationDisease Models, AnimalDurapatiteFemaleNanoparticlesOsteogenesisParticle SizeScapulaSheepSurgical WoundTransplantation, AutologousX-Ray MicrotomographyBone CementsBone SubstitutesDurapatite

Identifiers

PMID28233833
PMCPMC5324075
OpenAlexW2590662871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.